WDBMD acquires DZS Clinical Services, deal to leverage complementary CRO services, says CEO

By Maggie Lynch contact

- Last updated on GMT

Image: Getty/AndreyPopov)
Image: Getty/AndreyPopov)

Related tags: Contract research organization, CRO, acquistion, Clinical development, Biotech companies

DZS Clinical Services has been acquired by the global CRO WDMD in a deal that will expand its service offerings globally with the addition of coverage in Europe and Japan.

WDB Holdings’ subsidiary and contract research organization (CRO) WDB Medical Data (WDBMD) acquired DZS Clinical Services (DZS) and all its resources and processes.

Greg Ambra, president of DZS, told us the acquisition will leverage “synergies and complementary CRO services”​ between WDBND and DZS.

DZS provides clinical development and data analytic services, and the acquisition will “bolster its full-service CRO capabilities” ​while providing more coverage in Europe and Japan, according to Ambra.

The acquisition also will strengthen WDBMD’s capabilities and presence in the US. Ambra added, “WDBMD supplements DZS Clinical Services offering with pharmacovigilance and regulatory affairs services, in addition to access to a medical call center.”

The leadership team at DZS will remain intact and the company’s facilities in New Jersey will remain open with an additional office to be established in Sunnyvale, California.

Financial details were not disclosed. 

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars